Case 1 :04-cv-00179-SLR Document 115 Filed O3/30/2006 Page 1 of 2
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
BAYER AG, BAYER HEALTHCARE AG, )
and BAYER PHARMACEUTICALS )
CORPORATION )
)
Plaintiffs and )
Counterclajm Defendants, )
)
v. ) Civil Action No. 04-179 (SLR)
)
DR. REDDY’S LABORATORIES, LTD. and )
DR. REDDY’S LABORATORIES, INC., )
)
Defendants )
and Counterclaimants. )
)
O R D E R
Trial of this case, originally scheduled to commence on March 27, 2006, has been
postponed at the request of defendants/counterclajmants Dr. Reddy’s Laboratories, Ltd. and Dr.
Reddy’s Laboratories, Inc. (collectively "Reddy") and the Court has set a new trial date of
August 7, 2006, a delay of 133 days.
For the reasons stated on the record during the March 22, 2006 conference call
with the parties, and pursuant to the Court’s authority under 21 U.S.C. § 355(j)(5)(B)(iii);
IT IS HEREBY ORDERED that the expiration of "the thirty-month period" set
forth in 21 U.S.C. § 355(j)(5)(B)(iii) and 21 U.S.C. § 355(i)(5)(F)(ii), both relating to the
effective date of the approval of Reddy’s Abbreviated New Drug Application No. 76-938 for
Case 1 :04-cv-00179-SLR Document 115 Filed O3/30/2006 Page 2 of 2
moxifloxacin hydrochloride tablets, is hereby extended from June 10, 2007 until October 21,
2007.
SO ORDERED this $0% day of Q{4tA& , 2006.
Sue L. Robinson
Chief United States District Judge
2
Case 1:04-cv-00179-SLR
Document 115
Filed 03/30/2006
Page 1 of 2
Case 1:04-cv-00179-SLR
Document 115
Filed 03/30/2006
Page 2 of 2